Home  |  About the Book  |  Table of Contents  |  Search  |  Archive  |  Order  |  Visit JCO  |  Visit ASCO.org
ASCO Educational Book; 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar content in this book
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geier, L. J.
Right arrow Articles by Weitzel, J. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Geier, L. J.
Right arrow Articles by Weitzel, J. N.

Clinical Cancer Genetics Remains a Specialized Area: How Do I Get There From Here?

Larry J. Geier, MD, Therese M. Mulvey, MD, and Jeffrey N. Weitzel, MD

From the Kansas City Cancer Center, Kansas City, MO; Commonwealth Hematology Oncology PC, Quincy, MA; Division of Clinical Cancer Genetics, City of Hope, Duarte, CA

Authors’ disclosures of potential conflicts of interest are found at the end of this article.

Address reprint requests to Jeffrey N. Weitzel, MD, Director, Department of Clinical Cancer Genetics, Beckman Research Institute/City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010-0269, Tele; e-mail: jweitzel{at}coh.org

Overview: Oncologists are in a unique position to provide high-quality cancer genetic risk assessment in addition to the optimal management of that risk. This article focuses on practical aspects of launching a community-based program, including necessary education, several operational models, and reimbursement issues.